HeartSine Technologies LLC's samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P)

Automated External Defibrillators (non-wearable)

FDA Premarket Approval P160008

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the heartsine samaritan® pad 350p (sam 350p), pad 360p (sam 360p), and pad 450p (sam 450p) public access automated external defibrillators and battery/electrode accessories. These aeds are indicated for use on victims of cardiac arrest who are exhibiting the following signs: 1) unconscious; 2) not breathing; and 3) without circulation (without a pulse)the devices are intended for use by personnel who have been trained in their operation. Users should have received training in basic life support/aed, advanced life support or a physician-authorized emergency medical response training program. The devices are indicated for use on patients greater than 8 years old or over 55 lbs. (25 kg) when used with the adult pad-pak (pad-pak-01 or pad-pak-07). They are indicated for use on children between 1 and 8 years of age or up to 55 lbs. (25 kg) when used with the pediatric-pak (pad-pak-02).

DeviceHeartSine Technologies LLC's samaritan Public Access Automated External Defibrillators (SAM 350P, SAM 360P and SAM 450P)
Classification NameAutomated External Defibrillators (non-wearable)
Generic NameAutomated External Defibrillators (non-wearable)
ApplicantHeartSine Technologies LLC
Date Received2016-03-21
Decision Date2017-01-12
Notice Date2017-03-10
PMAP160008
SupplementS
Product CodeMKJ
Docket Number17M-0229
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address HeartSine Technologies LLC 121 Friends Lane suite 400 newton, PA 18940
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P160008Original Filing
S021 2022-11-01 30-day Notice
S020 2022-08-29 Real-time Process
S019 2022-03-28 Real-time Process
S018
S017
S016 2021-05-20 30-day Notice
S015 2020-10-28 30-day Notice
S014 2020-09-24 30-day Notice
S013
S012 2020-06-22 30-day Notice
S011
S010 2020-02-13 30-day Notice
S009
S008 2019-12-13 30-day Notice
S007 2019-10-31 30-day Notice
S006 2019-06-03 30-day Notice
S005 2019-02-01 30-day Notice
S004 2018-11-23 Real-time Process
S003 2018-11-21 30-day Notice
S002 2018-10-02 30-day Notice
S001 2018-09-11 30-day Notice

NIH GUDID Devices

Device IDPMASupp
05060167120695 P160008 004
05060167129773 P160008 004
05060167129735 P160008 004
05060167129711 P160008 004
05060167128066 P160008 004
05060167120916 P160008 004
05060167120893 P160008 004
05060167120886 P160008 004
05060167120701 P160008 004
05060167120671 P160008 004
05060167120688 P160008 004
05060167120718 P160008 004
05060167128080 P160008 004
05060167128042 P160008 004
05060167120909 P160008 004
05060167120862 P160008 004
05060167120855 P160008 004
05060167120725 P160008 004
M727PADPAK01 P160008 008
M727PADPAK02 P160008 008
05060167124488 P160008 008

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.